Inhibitory Antibodies against PCSK9 Reduce Surface CD36 and Mitigate Diet-Induced Renal Lipotoxicity-Reference-Cited by-同舟云学术

Inhibitory Antibodies against PCSK9 Reduce Surface CD36 and Mitigate Diet-Induced Renal Lipotoxicity

Published:2022-08-25 Issue:8 Volume:3 Page:1394-1410
ISSN:2641-7650
Container-title:Kidney360
language:en
Short-container-title:Kidney360

Author:

Byun Jae Hyun,Lebeau Paul F.,Platko Khrystyna,Carlisle Rachel E.,Faiyaz Mahi,Chen Jack,MacDonald Melissa E.,Makda Yumna,Yousof Tamana,Lynn Edward G.,Dickhout Jeffrey G.,Krepinsky Joan C.,Weaver Fiona,Igdoura Suleiman A.,Seidah Nabil G.,Austin Richard C.

Funder

Canadian Institutes of Health Research

Canada Research Chair

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference60 articles.

1. Global prevalence of chronic kidney disease—A systematic review and meta-analysis;Hill;PLoS One,2016

2. How does early chronic kidney disease progress? A background paper prepared for the UK Consensus Conference on early chronic kidney disease;Metcalfe;Nephrol Dial Transplant,2007

3. Body mass index, fatty liver index and other metabolic disturbances differentially affect albuminuria and glomerular filtration rate in the general population;Bigot;J Diabetes Metab,2014

4. The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: A pooled analysis;Singh;PLoS One,2013

5. Health effects of overweight and obesity in 195 countries over 25 years;Afshin;N Engl J Med,2017

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of PCSK9 in glomerular lipid accumulation and renal injury in diabetic kidney disease;Diabetologia;2024-06-15

2. PCSK9 deficiency promotes the development of peripheral neuropathy;2024-03-06

3. PCSK7: A novel regulator of apolipoprotein B and a potential target against non-alcoholic fatty liver disease;Metabolism;2024-01

4. Oxidative Stress Induced by Lipotoxicity and Renal Hypoxia in Diabetic Kidney Disease and Possible Therapeutic Interventions: Targeting the Lipid Metabolism and Hypoxia;Antioxidants;2023-12-06

5. Effect of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Podocytes in Mouse Nephrotic Syndrome;Laboratory Investigation;2023-09